TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Denali Therapeutics Announces Board and Executive Leadership Updates

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Denali Therapeutics Inc.
Denali Therapeutics Announces Board and Executive Leadership Updates

Denali Therapeutics appointed Tim Van Hauwermeiren to its Board of Directors and announced the departure of Chief Medical Officer Carole Ho to Eli Lilly, with Peter Chin assuming the Acting Chief Medical Officer role.

Insights
JAZZ   neutral

Mentioned as having an exclusive partnership with Zymeworks for zanidatamab development


DNLI   neutral

Routine leadership transition with internal promotion and strategic board addition